Verastem Inc - VSTM Quarterly EPS earnings growth

Corporate company logo of Verastem (VSTM)

The amplitude of quarterly EPS fluctuations on the GURU.Markets chart reflects the value of 44.70, combining with data on Verastem, Inc. (VSTM) partnerships with research centers to develop targeted therapies. Business development relies on attracting leading biochemists through stock option programs, while the stability of component supplies for trials is guaranteed by the global diversification of production sites.

verastem.com (VSTM) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/11/2026

Analytical breakdowns for Verastem, Inc.

- share price and consensus valuation forecast:
Stock Quotes Verastem|VSTM - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Verastem Inc|VSTM - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Verastem|VSTM - Accounting Value of Company|Market Capitalization to Book Value Ratio verastem.com|VSTM - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Capital Verastem, Inc.|VSTM - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Verastem, Inc.|VSTM - Company Cumulative Indebtedness|Debts to Book Capitalization Verastem Inc|VSTM - Long-Term Debt|Company Short-Term Debts Verastem|Quick Liquidity Indicator verastem.com
- earnings and market multiples details:
VSTM - Final Profit|Future Profit Verastem, Inc.|VSTM - Market Price to Net Income Ratio|Forward P/E Multiple Verastem Inc|VSTM - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Verastem Inc|VSTM - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Verastem|VSTM - Earnings per share for the trailing year|Quarterly EPS earnings growth verastem.com|VSTM - Earnings growth in current year|Net earnings per share growth forecast for next year Verastem, Inc.
Fundamental company valuation:Verastem - VSTM
Flagship merchandise of verastem.com

The long-term reliability of Verastem, Inc. (VSTM) is determined by the stability of its earnings per share generation. This indicator captures the percentage change in quarterly net income, reflecting the dynamics of the business's operational efficiency. By analyzing the intensity of quarterly EPS growth, investors assess the speed of profit scaling relative to previous periods. A positive trend confirms the financial return from the robotization of screening and the implementation of bioinformatic AI. The automation of molecule discovery reduces costs, directly influencing the final profitability vector.

Analysis of competing companies

GMAB (Genmab) - Year-over-year net earnings per share growth for the last 12 months|EXEL: Year-over-year earnings per share growth rate for the last twelve months|NUVL (Nuvalent Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Kymera Corp|Year-over-year earnings per share growth for the last twelve months IDEAYA Biosciences (IDYA)|ELVN (enliventherapeutics.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORIC (ORIC Pharmaceuticals, Inc.)|Net earnings per share growth for the trailing year Relay Therapeutics Inc|Nurix Pharma - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tyra Corp|GLUE (Monte Rosa Therapeutics) - Year-over-year net earnings per share growth for the last 12 months|CGEM: Year-over-year earnings per share growth rate for the last twelve months|IMRX (Immuneering) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months C4 Therapeutics Inc CCCC|Quarterly EPS earnings growth BDTX|Repare Therapeutics Inc - Year-over-year earnings per share growth for the last 12 months|PMV Pharmaceuticals - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months KPTI|PPCB: Year-over-year net earnings per share growth for the last 12 months|Bio Green Med Solution Inc. - Year-over-year earnings per share growth rate for the last twelve months|AADI: Quarterly EPS earnings growth|Aileron Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|BPMC (Blueprint Medicines Corp.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months GlycoMimetics Corp GLYC|Year-over-year earnings per share growth for the last twelve months SpringWorks Therapeutics, Inc. (SWTX)